ADC Pharmacokinetics and Clinical Pharmacology Summit
Evvnt Promotion / evvnt
Archiv
08.10.2024 - 10.10.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 am to 5:00 pm
Kongressthemen
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.
Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in development. Despite their success, the therapeutic window remains relatively narrow, posing challenges for finding an optimal dose.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/2465910-3?pid=4832
Speakers: Alison Betts, Global Head of DMPK and Modeling, Takeda, Andras Strassz, Chief Medical Officer, Heidelberg Pharma Research GmbH and more
Brochure: https://go.evvnt.com/2465910-3?pid=4832
Speakers: Alison Betts, Global Head of DMPK and Modeling, Takeda, Andras Strassz, Chief Medical Officer, Heidelberg Pharma Research GmbH and more
Anfragen und Anmeldung:
https://go.evvnt.com/2465910-1?pid=4832
Frau Abigail Cox
Gesundheitsversorgung
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
